These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 33739563)
1. Brain insulin, insulin-like growth factor 1 and glucagon-like peptide 1 signalling in Alzheimer's disease. Ferreira ST J Neuroendocrinol; 2021 Apr; 33(4):e12959. PubMed ID: 33739563 [TBL] [Abstract][Full Text] [Related]
2. The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications. Zemva J; Schubert M CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):322-37. PubMed ID: 24059318 [TBL] [Abstract][Full Text] [Related]
3. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease. Hölscher C Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319 [TBL] [Abstract][Full Text] [Related]
4. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. de la Monte SM; Wands JR J Alzheimers Dis; 2005 Feb; 7(1):45-61. PubMed ID: 15750214 [TBL] [Abstract][Full Text] [Related]
5. New roles for insulin-like hormones in neuronal signalling and protection: new hopes for novel treatments of Alzheimer's disease? Hölscher C; Li L Neurobiol Aging; 2010 Sep; 31(9):1495-502. PubMed ID: 18930564 [TBL] [Abstract][Full Text] [Related]
6. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? Steen E; Terry BM; Rivera EJ; Cannon JL; Neely TR; Tavares R; Xu XJ; Wands JR; de la Monte SM J Alzheimers Dis; 2005 Feb; 7(1):63-80. PubMed ID: 15750215 [TBL] [Abstract][Full Text] [Related]
7. Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease. O'Neill C; Kiely AP; Coakley MF; Manning S; Long-Smith CM Biochem Soc Trans; 2012 Aug; 40(4):721-7. PubMed ID: 22817723 [TBL] [Abstract][Full Text] [Related]
8. The impairment of insulin signaling in Alzheimer's disease. Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399 [TBL] [Abstract][Full Text] [Related]
9. Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification? Bassil F; Fernagut PO; Bezard E; Meissner WG Prog Neurobiol; 2014 Jul; 118():1-18. PubMed ID: 24582776 [TBL] [Abstract][Full Text] [Related]
11. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. Rivera EJ; Goldin A; Fulmer N; Tavares R; Wands JR; de la Monte SM J Alzheimers Dis; 2005 Dec; 8(3):247-68. PubMed ID: 16340083 [TBL] [Abstract][Full Text] [Related]
12. Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of Aβ Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model. Selles MC; Fortuna JTS; Zappa-Villar MF; de Faria YPR; Souza AS; Suemoto CK; Leite REP; Rodriguez RD; Grinberg LT; Reggiani PC; Ferreira ST Mol Neurobiol; 2020 Mar; 57(3):1473-1483. PubMed ID: 31760608 [TBL] [Abstract][Full Text] [Related]
13. Central insulin and insulin-like growth factor-1 signaling: implications for diabetes associated dementia. Zemva J; Schubert M Curr Diabetes Rev; 2011 Sep; 7(5):356-66. PubMed ID: 21916834 [TBL] [Abstract][Full Text] [Related]
14. Insulin signalling in Alzheimer's disease and diabetes: from epidemiology to molecular links. Ribe EM; Lovestone S J Intern Med; 2016 Nov; 280(5):430-442. PubMed ID: 27739227 [TBL] [Abstract][Full Text] [Related]
15. Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease. Bomba M; Granzotto A; Castelli V; Onofrj M; Lattanzio R; Cimini A; Sensi SL J Alzheimers Dis; 2019; 70(3):793-810. PubMed ID: 31256135 [TBL] [Abstract][Full Text] [Related]
16. Brain insulin resistance: role in neurodegenerative disease and potential for targeting. Hölscher C Expert Opin Investig Drugs; 2020 Apr; 29(4):333-348. PubMed ID: 32175781 [No Abstract] [Full Text] [Related]
17. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. Talbot K; Wang HY; Kazi H; Han LY; Bakshi KP; Stucky A; Fuino RL; Kawaguchi KR; Samoyedny AJ; Wilson RS; Arvanitakis Z; Schneider JA; Wolf BA; Bennett DA; Trojanowski JQ; Arnold SE J Clin Invest; 2012 Apr; 122(4):1316-38. PubMed ID: 22476197 [TBL] [Abstract][Full Text] [Related]
18. Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. Liu Y; Liu F; Grundke-Iqbal I; Iqbal K; Gong CX J Pathol; 2011 Sep; 225(1):54-62. PubMed ID: 21598254 [TBL] [Abstract][Full Text] [Related]
19. Possible usefulness of growth hormone/insulin-like growth factor-I axis in Alzheimer's disease treatment. Sáez JM Endocr Metab Immune Disord Drug Targets; 2012 Sep; 12(3):274-86. PubMed ID: 22524398 [TBL] [Abstract][Full Text] [Related]
20. The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease. Talbot K; Wang HY Alzheimers Dement; 2014 Feb; 10(1 Suppl):S12-25. PubMed ID: 24529520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]